Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
EDIT
Editas Medicine
Last Price:
3.39
Seasonality Move:
22%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.36 | Buy |
20-day SMA: | 3.6 | Sell |
50-day SMA: | 3.96 | Sell |
200-day SMA: | 6.19 | Sell |
8-day EMA: | 3.38 | Buy |
20-day EMA: | 3.55 | Sell |
50-day EMA: | 3.96 | Sell |
200-day EMA: | 5.77 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 39.94 | Sell |
Chaikin Money Flow: | 457652 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.38 - 3.82) | Sell |
Bollinger Bands (100): | (3.8 - 5.48) | Sell |
Editas Medicine Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.38 while EDIT 8-day simple moving average is 3.36, which is a Buy signal.
- The stock price of EDIT is 3.38 while Editas Medicine 20-day SMA is 3.60, which makes it a Sell.
- Editas Medicine 50-day simple moving average is 3.96 while EDIT share price is 3.38, making it a Sell technically.
- EDIT stock price is 3.38 and Editas Medicine 200-day simple moving average is 6.19, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
38
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Sell
The current Editas Medicine [EDIT] share price is $3.38. The Score for EDIT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
278.77M
Price in USD:
3.38
Share Volume:
3.07M
Editas Medicine 52-Week Range
52-Week High:
11.69
52-Week Low:
3.15
Sell
38
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 3.38 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.38 while EDIT 8-day exponential moving average is 3.38, which is a Buy signal.
- The stock price of EDIT is 3.38 while Editas Medicine 20-day EMA is 3.55, which makes it a Sell.
- Editas Medicine 50-day exponential moving average is 3.96 while EDIT share price is 3.38, making it a Sell technically.
- EDIT stock price is 3.38 and Editas Medicine 200-day simple moving average is 5.77, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 39.94, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (3.38 - 3.82), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (3.8 - 5.48), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.